Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the ...

Q3 2024 Earnings Call Transcript November 12, 2024 Megan LeDuc: Good evening. I’m Megan LeDuc, Manager of Investor Relations ...

Ginkgo Bioworks is headquartered at 27 Drydock Avenue in Boston's Seaport. Ginkgo has canceled its planned move into a ...

In this article, we are going to take a look at where Merck & Co. Inc. (NYSE ... Earlier in October, Jason Trennert, Strategas Research Partners chairman and CEO, joined CNBC to discuss the ...

Ginkgo provides update on its restructuring process including an acceleration of site consolidation initiatives and continued progress on cost reductions Ginkgo signs ...

Earlier in October, Jason Trennert, Strategas Research Partners ... beating its benchmark by 150 percentage points (see more details here). Merck & Co. Inc. (NYSE:MRK) is a global pharmaceutical ...

In a report released yesterday, Jason Zemansky from Bank of America Securities maintained a Hold rating on Arcus Biosciences (RCUS – ...

Updated clinical data from VISTA101 presented at SITC 2024.Monotherapy arm fully enrolled and combination arm expected to be fully enrolled by ...

Taking a new tack There's no word yet on the drug targets that will be explored in the Cerevance partnership, but Merck head of neuroscience discovery, Jason Uslaner, said that the collaboration ...

Operator Good day, ladies and gentlemen, and welcome to Exelixis' third quarter 2024 financial results conference call. My ...

Teledyne Technologies Incorporated today announced that George Bobb, President and Chief Operating Officer, and Jason VanWees, Vice Chairman, will participate at the Baird 2024 Global Industrial ...

Frazier, the former CEO of pharmaceutical company Merck &. Co, donated the most out ... Tom Emmer (R-Minn.), and Rep. Jason Smith (R-Mo.). He also donated $6,600 to Rep. Andy Kim (D-N.J.). Other ...